Ureteral Access Sheath Market (2026 - 2033) Size, Share, & Trends Analysis Report By Product Type (Standard (Single-Lumen), Reinforced, Dual-Lumen), By Clinical Indication (Stone Management), By Age Group, By Size, By End Use (Hospitals, Specialty Clinics), And Segment Forecasts

Ureteral Access Sheath Market Summary

The global ureteral access sheath market size was valued at USD 609.56 million in 2025 and is projected to reach USD 1,068.85 million by 2033, growing at a CAGR of 7.18% from 2026 to 2033. The ureteral access sheath market is primarily driven by the rising prevalence of urolithiasis and other urological disorders, which have increased the volume of ureteroscopy procedures globally.

The growing adoption of minimally invasive surgeries, coupled with technological advancements that improve procedural efficiency, safety, and reduce operative time, is further accelerating market growth. According to the National Kidney Foundation, more than 500,000 people visit emergency rooms each year due to kidney stones, highlighting the significant clinical burden of the condition. In nearly 1 in 10 individuals, a kidney stone is expected to develop at some point during their lifetime. The rising prevalence of urolithiasis is a key driver of growth in the ureteral access sheath market, as increasing stone cases directly increase the number of ureteroscopic procedures. Ureteral access sheaths are essential in stone management, enabling efficient scope exchanges and improved intrarenal pressure control. As kidney stone incidence continues to grow due to lifestyle and dietary changes, demand for advanced ureteral access devices is expected to increase significantly. According to the National Kidney Foundation, in 2025, approximately 1 in 10 people have experienced a kidney stone at some point in their lives. The condition is slightly more common among men, with about 11 out of every 100 affected, compared to around 9 out of every 100 women.

The growing adoption of minimally invasive urological procedures is a key driver of the ureteral access sheath market, as these procedures depend on safe, efficient ureteral access. Procedures such as ureteroscopy, retrograde intrarenal surgery (RIRS), and laser lithotripsy use access sheaths to facilitate smooth instrument exchange and improve intrarenal pressure control. The shift toward shorter hospital stays, reduced complications, and faster recovery continues to accelerate demand for ureteral access sheaths.

For instance, a 2025 study published in the Journal of Urological Surgery compared the impact of multiple sessions of retrograde intrarenal surgery (RIRS) with single-access conventional percutaneous nephrolithotomy (PCNL) on acute kidney injury (AKI) in patients with nephrolithiasis. The retrospective analysis included patients who underwent multiple RIRS procedures within three months in the same renal unit and those who received single-access PCNL between January 2018 and December 2023.

Source: Journal of Urological Surgery

The study comparing multiple RIRS procedures with single-access PCNL shows that minimally invasive stone management approaches, such as RIRS, are adopted, particularly when renal function preservation and lower procedural invasiveness are priorities. Since RIRS relies heavily on endoscopic access through the ureter, the need for safe, repeatable ureteral access is critical. The increasing preference for minimally invasive stone treatment techniques, such as RIRS, is expected to drive consistent demand for ureteral access sheaths, as they are essential tools for safe and efficient endoscopic kidney stone management.

Technological advancements are significantly driving the ureteral access sheath market by improving procedural safety, efficiency, and clinical outcomes. Innovations such as enhanced flexible materials, hydrophilic coatings, pressure-controlled and dual-lumen designs help reduce ureteral trauma and maintain optimal intrarenal pressure. These developments support wider adoption of ureteral access sheaths across complex and minimally invasive urological procedures.

For instance, in August 2025, the Journal of the Formosan Medical Association reported that urolithiasis remains a prevalent and economically burdensome condition worldwide, with a high recurrence rate. Advances in flexible ureteroscopes (fURS) and high-power holmium laser (HPHL) technologies have broadened clinical indications, positioning retrograde intrarenal surgery (RIRS) as a preferred treatment for complex upper urinary tract stones. The introduction of flexible and navigable suction (FANS) ureteral access sheaths (UAS) has further improved outcomes by enabling effective intrarenal pressure control and high stone-free rates, with minimal serious adverse events. However, alongside these clinical benefits, the rising costs of disposable fURS and HPHL systems are emerging as a significant concern in contemporary stone management.

Market Concentration & Characteristics

The ureteral access sheath market is moderately concentrated, with a few established medical device companies holding a significant share due to strong brand presence, regulatory expertise, and broad distribution networks. The market is characterized by continuous product innovation, strict regulatory compliance, and a focus on minimally invasive urological procedures.

The degree of innovation in the ureteral access sheath market is advancing rapidly, with manufacturers focusing on enhanced materials, improved flexibility, and ergonomic designs to support safer and more efficient ureteroscopic procedures. Innovations such as dual-lumen configurations, pressure-controlled systems, and coatings that reduce friction are improving clinical outcomes and expanding procedural applications. These technological advancements are driving greater adoption among urologists and fueling competitive growth within the market.

Regulatory frameworks significantly impact the ureteral access sheath market by ensuring product safety, efficacy, and quality through stringent approval processes such as FDA clearance and CE marking. Compliance with evolving medical device regulations increases development costs and time-to-market and builds clinician and patient confidence in these devices. In addition, post-market surveillance and reporting requirements help identify and mitigate potential risks, further shaping competitive dynamics and innovation strategies within the market.

The ureteral access sheath market has seen moderate merger and acquisition activity as larger medical device companies seek to expand their urology portfolios and gain access to innovative technologies. Strategic acquisitions help companies broaden product offerings, enhance geographic reach, and leverage established distribution networks. This consolidation trend is expected to continue as firms aim to strengthen competitive positioning and capitalize on growing demand for advanced urological solutions.

In January 2026, Boston Scientific announced an agreement to acquire Valencia Technologies Corporation to expand its urology portfolio, particularly in overactive bladder (OAB) treatment. The Boston Scientific acquisition of Valencia Technologies reflects the broader expansion of minimally invasive urology treatments, which, in turn, supports the ureteral access sheath market. As urology procedure volumes increase and healthcare providers invest more in advanced endoscopic infrastructure, procedures such as RIRS are expected to grow. Since ureteral access sheaths are routinely used during RIRS to enable safe and repeated scope access, improving procedural efficiency and safety, the rising adoption of minimally invasive urology interventions is expected to drive demand for UAS products.

The ureteral access sheath market is experiencing rapid product expansion, with companies introducing sheaths featuring advanced materials, enhanced flexibility, and improved lumens to meet diverse clinical needs. Newer offerings focus on reducing ureteral trauma, optimizing irrigation flow, and supporting a wider range of endoscopic instruments. This continuous innovation and broadening of product portfolios are helping manufacturers capture more market share and address evolving surgeon preferences.

Regional expansion in the ureteral access sheath market is gaining momentum as manufacturers target emerging markets in Asia-Pacific, Latin America, and the Middle East, where demand for advanced urological treatments is rising. Increasing healthcare infrastructure investments, growing patient awareness, and improving reimbursement frameworks are encouraging market entry and distribution network growth. Strategic partnerships with local distributors and training initiatives for clinicians are further supporting adoption across these expanding regions.

Product Type Insights

The standard (single lumen) segment dominates the ureteral access sheath market in 2025 due to its widespread use in routine ureteroscopy procedures, particularly for stone management. These sheaths are preferred for their simpler design, cost-effectiveness, and proven clinical reliability across a broad patient population. Their compatibility with most ureteroscopes and ease of handling continue to support strong adoption in both hospital and ambulatory settings.

The dual-lumen segment in the ureteral access sheath market is expected to grow faster during the forecast period, driven by its ability to provide simultaneous irrigation and pressure management during complex ureteroscopy procedures. These sheaths enhance visibility, improve stone clearance efficiency, and help reduce intrarenal pressure, supporting better clinical outcomes. Increasing adoption in advanced stone management and complex urological cases is further accelerating the growth of the dual-lumen segment.

Size Insights

The 10–12 Fr segment dominated in ureteral access sheath market in 2025, as this size range offers an optimal balance between adequate working channel access and patient safety. These sheaths are widely used in standard ureteroscopy stone management procedures because they are compatible with most flexible ureteroscopes. Their broad clinical acceptance and suitability for adult patients continue to support strong market dominance.

The <10 Fr segment of the ureteral access sheath market is expected to grow faster during the forecast period, driven by rising demand for minimally invasive and pediatric urological procedures. Smaller-diameter sheaths help reduce ureteral trauma and postoperative complications, making them increasingly preferred in delicate and complex cases. Technological advancements that enable greater flexibility and durability in thinner sheaths are further supporting the growth of this segment.

Age Group Insights

The adult segment dominated the ureteral access sheath market in 2025, largely due to the higher prevalence of urolithiasis and other urological disorders among adults. Adults account for the majority of ureteroscopy procedures, where access sheaths are routinely used to improve procedural efficiency and safety. In addition, lifestyle factors and age-related risks continue to drive greater demand for ureteral interventions in this segment.

The pediatric segment of the ureteral access sheath market is expected to grow faster during the forecast period, driven by rising diagnoses of pediatric urolithiasis and congenital urological disorders. Growing awareness among clinicians, along with advancements in smaller-diameter and more flexible access sheaths designed specifically for children, is supporting adoption. In addition, rising preference for minimally invasive pediatric urological procedures is further accelerating growth in this segment.

Clinical Indication Insights

The stone management segment dominates the ureteral access sheath market in 2025 and is also expected to grow fastest in the forecast period, driven by the high global burden of kidney and ureteral stones and the rising volume of ureteroscopic procedures. Ureteral access sheaths are widely used in stone removal and laser lithotripsy, as they facilitate smooth instrument exchange and maintain low intrarenal pressure. Their ability to enhance procedural efficiency, reduce operative time, and lower complication risks continues to drive strong adoption in stone management applications.

The other segment in the ureteral access sheath market is witnessing significant growth, supported by expanding applications beyond stone management, including tumor biopsies, ureteral strictures, and diagnostic ureteroscopy. Increasing adoption of minimally invasive urological procedures and improved sheath designs that enhance flexibility and access are contributing to this growth. In addition, rising clinician preference for versatile devices across multiple indications is accelerating the segment's expansion.

End Use Insights

Hospitals dominate the ureteral access sheath market due to their role as the primary centers for managing complex urological conditions and performing high-volume endourological procedures such as ureteroscopy. These settings are equipped with advanced surgical infrastructure, imaging systems, and skilled urologists, enabling safe and efficient use of ureteral access sheaths. In addition, the rising number of inpatient and outpatient kidney stone procedures, along with the preference for minimally invasive surgery, further strengthens hospital demand for these devices.

The ambulatory surgery centers (ASCs) segment is expected to grow the fastest during the forecast period in the ureteral access sheath market, driven by the increasing shift of urological procedures from hospitals to outpatient settings. ASCs offer cost-effective treatment, shorter procedure times, and faster patient recovery, making them an attractive option for minimally invasive ureteroscopic interventions. The growing adoption of advanced endourology technologies and favorable reimbursement policies further support the rapid expansion of this segment.

Regional Insights

North America dominated the negative pressure wound therapy market with the largest revenue share of 32.57% in 2025. TheNorth Americaureteral access sheath market is growing due to the rising incidence of urinary stone disease and a greater preference for minimally invasive urological procedures. Healthcare providers in the region are adopting advanced sheath technologies that improve procedural efficiency and patient outcomes. Strong healthcare infrastructure, higher healthcare spending, and supportive reimbursement frameworks further fuel market growth. In addition, ongoing clinical awareness and investment in urology services continue to strengthen North America’s market position.

U.S. Ureteral Access Sheath Market Trends

The U.S. ureteral access sheath market is experiencing significant growth, driven by the increasing prevalence of kidney stone disease and the widespread adoption of minimally invasive urological procedures. Ongoing innovations in sheath design and materials are improving procedural safety and efficiency, encouraging higher clinical adoption. In addition, strong healthcare infrastructure, favorable reimbursement policies, and the growing shift toward outpatient urology procedures continue to support market expansion.

The AUA 2026 kidney stone surgery guideline is expected to support the growth of the U.S. ureteral access sheath market. Ureteroscopy (URS) is a key treatment that supports the use of ureteral access sheaths during URS procedures. The guideline recommends URS as a primary treatment option for many kidney and ureteral stones. It allows the use of ureteral access sheaths, including advanced suction-based designs, during URS, thereby increasing clinical adoption of UAS devices. The U.S. already performs a high and growing volume of stone surgeries, with ureteroscopy procedures rising significantly over the last decade, creating sustained procedural demand for access tools such as UAS.

AUA 2026 Kidney Stone Surgery Guideline – Key Recommendations Summary Table

Source:  American Urological Association Education and Research, Inc., 2026

Europe Ureteral Access Sheath Market Trends

The Europe ureteral access sheath market is experiencing growth, driven by an increasing prevalence of kidney stone disease and broader adoption of minimally invasive urological procedures such as flexible ureteroscopy (fURS) and retrograde intrarenal surgery (RIRS). Well-established healthcare infrastructure across Western Europe, supported by reimbursement frameworks, enables high procedure volumes and the routine use of advanced endourology devices. Clinical guidelines from leading professional bodies, such as the European Association of Urology (EAU), continue to emphasize evidence-based management of urolithiasis, supporting best practices and encouraging the use of procedural accessories, such as access sheaths. Growth is also supported by continual investment in hospital and ambulatory surgical center capabilities, increasing availability of hydrophilic-coated and dual-lumen sheaths that improve procedural efficiency and patient outcomes, and technology adoption aimed at reducing complications and recovery times.

The UK ureteral access sheath market is growing as part of the broader expansion of minimally invasive urology procedures, driven by rising volumes of flexible ureteroscopy (fURS) and related interventions for kidney stone disease, ureteral obstruction, and other urological conditions. Adoption of advanced endourological techniques and disposable technologies is supported by investments within the National Health Service (NHS) to enhance procedural capacity, improve treatment outcomes, and modernize surgical practice. Government-led health strategy reforms, including the NHS 10-Year Health Plan, which aims to shift care toward prevention, community services, and digital integration, are expected to improve early disease detection and streamline access to specialist care. NHS initiatives such as the Think Kidneys acute kidney Programme and the Renal Services Transformation Programme focus on enhancing prevention, early diagnosis, and integrated care for kidney conditions, which indirectly support demand for diagnostic and surgical tools used in stone management and endourology. Moreover, efforts to reduce waiting times, expand community-based services, and promote innovation in surgical technologies signal a favorable policy environment for technologies associated with ureteral access and urology procedural growth.

The Germany ureteral access sheath market is experiencing growth supported by a well-established healthcare infrastructure and high procedure volumes. Germany maintains one of the largest and most advanced urology markets in Europe, driven by the widespread adoption of minimally invasive procedures such as flexible ureteroscopy (fURS) and laser-assisted stone management, as clinical practice shifts away from traditional modalities, such as shock wave lithotripsy, toward endoscopic techniques. Population aging and the associated rising incidence of urological conditions, particularly kidney stones, benign prostatic hyperplasia (BPH), and other urinary tract disorders, contribute to increased procedural demand.

According to the Federal Ministry of Health of Germany, in Germany, kidney and ureteral stones affect approximately 1–2% of the population each year, with a higher incidence among men than women.

Asia Pacific Ureteral Access Sheath Market Trends

The Asia Pacific ureteral access sheath market is growing, supported by the rising prevalence of kidney stone disease and other urological conditions, expanding healthcare infrastructure, and the increasing adoption of minimally invasive procedures such as flexible ureteroscopy (fURS) and retrograde intrarenal surgery (RIRS). Countries such as China, India, Japan, and South Korea are major contributors, driven by large patient populations, improving access to advanced endourology services in both urban and tier-2/3 cities, and growing private healthcare investment. Rising healthcare spending and government support for advanced medical technologies are enabling the broader use of endoscopic and disposable devices, while increased procedural volumes in hospitals and ambulatory surgical centers further drive demand for accessories such as ureteral access sheaths. The region’s rapid adoption of digital and single-use solutions, along with collaborations between global manufacturers and local distributors, is also enhancing device availability and affordability.

The India ureteral access sheath market is growing as part of the broader expansion of the urology devices and ureteroscopy market, supported by the rising prevalence of urological conditions such as kidney stones (urolithiasis), benign prostatic hyperplasia, and other urinary tract disorders, particularly among an aging and urbanizing population. Increasing procedural volumes for flexible ureteroscopy (fURS) and related minimally invasive surgeries, driven by greater clinician preference and improved patient outcomes, are contributing to higher demand for accessories, including ureteral access sheaths. Growth in the overall urology devices segment is driven by expanding healthcare infrastructure, with more hospitals and specialty centers adopting advanced endourology equipment and techniques, and rising awareness of early diagnosis and treatment of urological diseases.

“We are seeing an unprecedented rise in kidney stone cases, especially among young adults and children. The soaring heat and insufficient hydration are the primary culprits. What’s particularly concerning is the increasing trend in school children, largely driven by high junk food consumption. Stones are not just a problem of adults anymore,” said Dr. Taif Bendegeri, Senior Consultant Urologist at Asian Institute of Nephrology and Urology.

The China ureteral access sheath market is primarily driven by the increasing prevalence of urinary stone disease (urolithiasis), particularly kidney stones and ureteral stones, which have become more common due to lifestyle changes and metabolic factors, leading to rising volumes of flexible ureteroscopy (fURS) and retrograde intrarenal surgery (RIRS) procedures. In addition to stone disease, conditions such as ureteral obstruction from strictures or tumors and complications associated with metabolic disorders further fuel demand for minimally invasive endourology devices.

The Healthy China 2030 initiative is also strengthening the market by prioritizing improvements in healthcare infrastructure, expanding access to quality medical services, and promoting preventive and early diagnostic care, which collectively enhance capacity for urological diagnostics and treatments. This government strategy aims to expand the overall health services system and health industry, improve healthcare access and equity, and accelerate innovation in medical technology, thereby creating a favorable policy environment that supports broader adoption of advanced urology devices, including ureteral access sheaths.

Latin America Ureteral Access Sheath Market Trends

The Latin America ureteral access sheath market is growing, driven by expanding healthcare infrastructure and the increasing adoption of hydrophilic-coated ureteral access sheaths, which improve ease of insertion and reduce ureteral trauma. Rising procedural volumes of flexible ureteroscopy (fURS) and retrograde intrarenal surgery (RIRS) for kidney stone management are key contributors to market growth, particularly in countries such as Brazil and Argentina. Improved availability of advanced endourology devices, growing investment in private hospitals, and increasing clinician preference for minimally invasive techniques are further supporting adoption.

Middle East & Africa Ureteral Access Sheath Trends

The Middle East & Africa (MEA) ureteral access sheath market is experiencing growth, driven by increasing investments in healthcare infrastructure, particularly in Gulf Cooperation Council (GCC) countries such as Saudi Arabia and the UAE, where advanced urology and minimally invasive surgical capabilities are expanding. Rising awareness of urological disorders, including kidney stone disease, and a gradual shift toward minimally invasive endourology procedures are driving demand for ureteral access sheaths across the region. In addition, the development of private hospitals, the growth of medical tourism, and collaborations between international device manufacturers and regional distributors are improving access to advanced urology devices.

Key Ureteral Access Sheath Company Insights

The ureteral access sheath market is highly competitive, with key players holding significant positions. The major companies are undertaking various organic as well as inorganic strategies such as new product development, collaborations, acquisitions, mergers, and regional expansion for serving the unmet needs of their customers.

Recent Developments

• In September 2025, Olympus Corporation announced an exclusive global distribution partnership with MacroLux Medical Technology to expand its single-use urology product portfolio. The agreement covers single-use cystoscopes, ureteroscopes, and suction access sheaths used to diagnose and treat urinary tract conditions, such as kidney stones.

• In September 2025, Dornier MedTech announced the full U.S. commercial launch of two single-use urology devices: the Hoover Flexible and Navigable Suction Ureteral Access Sheath and the Axis II Slim ureteroscope. The Hoover sheath enables continuous irrigation, suction, and instrument exchange during stone procedures, improving visibility and reducing procedure time.

“Dornier MedTech America has a deep understanding of urological workflows and urologists’ needs. The Dornier Hoover delivers best-in-class suction performance and Dornier Axis II Slim offers best-in-class deflection—giving urologists a proven competitive edge in the operating theater,” CEO Brock Faulkner 

Ureteral Access Sheath Market Report Scope

Global Ureteral Access Sheath Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the ureteral access sheath market report on the basis of product type, size, age group, clinical indication, end use and region:

• Product Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Standard (Single-Lumen)

  • Reinforced

  • Dual‑Lumen

• Size Outlook (Revenue, USD Million, 2021 - 2033)

  • <10

  • 10 to 12

  • More than or equal to 13 - 15

• Age Group Outlook (Revenue, USD Million, 2021 - 2033)

  • Adult

  • Pediatric

• Clinical Indication Outlook (Revenue, USD Million, 2021 - 2033)

  • Stone Management

  • Others

• End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospitals

  • Specialty Clinics

  • Diagnostic Centers

  • ASCs

  • Others

• Region Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait